Drug Approval | May 11, 2022
Alembic Pharmaceuticals receives USFDA approval for Arformoterol Tartrate
This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
The approved product has a market size of US $ 1172 million for the twelve months ending March 2022, according to IQVIA
Bortezomib for injection is used to treat certain types of cancer such as multiple myeloma and mantle cell lymphoma
Covaxin was earlier approved for children 12-18 years of age
The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat
This product is indicated for the short-term treatment of a breathing problem (apnea) in premature infants
Essent continues to broaden its highly characterized, low passage primary cell catalog
Makrolon polycarbonate is key to needle-free injections that can stand up to sterilization
Cabenuva was co-developed as part of a collaboration with ViiV Healthcare and builds on Janssen's decades-long commitment to combatting HIV
The drug is indicated for use in combination with other drugs
Subscribe To Our Newsletter & Stay Updated
